Subcutaneous injection versus subcutaneous infusion of insulin: are the rates of absorption truly the same?

about

Suspension of basal insulin to avoid hypoglycemia in type 1 diabetes treated with insulin pump.Insulin infusion set: the Achilles heel of continuous subcutaneous insulin infusion Confusion Regarding Duration of Insulin Action: A Potential Source for Major Insulin Dose Errors by Bolus Calculators.

P2860

Q34850888-38CD6DC6-4171-437C-892E-6E639E87F327 Q38037730-3E49505E-BD0F-4736-BF7D-E6CF29D1E0CF Q41873997-CBC09CA5-6723-497C-962D-0F110ACF237B

P2860

Subcutaneous injection versus subcutaneous infusion of insulin: are the rates of absorption truly the same?

Item

http://www.wikidata.org/entity/Q42959127

description

2011 nî lūn-bûn

@nan

2011年の論文

@ja

2011年論文

@yue

2011年論文

@zh-hant

2011年論文

@zh-hk

2011年論文

@zh-mo

2011年論文

@zh-tw

2011年论文

@wuu

2011年论文

@zh

2011年论文

@zh-cn

name

Subcutaneous injection versus ...... of absorption truly the same?

@en

Subcutaneous injection versus ...... of absorption truly the same?

@nl

type

Item

label

Subcutaneous injection versus ...... of absorption truly the same?

@en

Subcutaneous injection versus ...... of absorption truly the same?

@nl

prefLabel

Subcutaneous injection versus ...... of absorption truly the same?

@en

Subcutaneous injection versus ...... of absorption truly the same?

@nl

P1476

Subcutaneous injection versus ...... of absorption truly the same?

@en

P2093

Solomon Steiner

http://www.w3.org/2001/XMLSchema#string

P2860

Premeal injection of rapid-acting insulin reduces postprandial glycemic excursions in type 1 diabetes.

Reduction of postprandial glycemic excursions in patients with type 1 diabetes: a novel human insulin formulation versus a rapid-acting insulin analog and regular human insulin.

Effect of age of infusion site and type of rapid-acting analog on pharmacodynamic parameters of insulin boluses in youth with type 1 diabetes receiving insulin pump therapy.

Insulin pump therapy: what is the evidence for using different types of boluses for coverage of prandial insulin requirements?

Insulin absorption from lipodystrophic areas: a (neglected) source of trouble for insulin therapy?

A novel insulin formulation with a more rapid onset of action.

Microneedle-based intradermal versus subcutaneous administration of regular human insulin or insulin lispro: pharmacokinetics and postprandial glycemic excursions in patients with type 1 diabetes.

The pharmacokinetics of insulin after continuous subcutaneous infusion or bolus subcutaneous injection in diabetic patients.

Intradermal microneedle delivery of insulin lispro achieves faster insulin absorption and insulin action than subcutaneous injection.

P304

1027-1029

http://www.w3.org/2001/XMLSchema#string

P31

scholarly article

editorial

P356

10.1177/193229681100500501

http://www.w3.org/2001/XMLSchema#string

P433

http://www.w3.org/2001/XMLSchema#string

P478

http://www.w3.org/2001/XMLSchema#string

P50

Lutz Heinemann

P577

2011-09-01T00:00:00Z

http://www.w3.org/2001/XMLSchema#dateTime

P5875

51745329

http://www.w3.org/2001/XMLSchema#string

P698

22027293

http://www.w3.org/2001/XMLSchema#string

P921

Insulin

P932

3208856

http://www.w3.org/2001/XMLSchema#string

Subcutaneous injection versus subcutaneous infusion of insulin: are the rates of absorption truly the same?

about

P2860

P2860

Subcutaneous injection versus subcutaneous infusion of insulin: are the rates of absorption truly the same?

description

name

type

label

prefLabel

P1433

P1476

P2093

P2860

P304

P31

P356

P433

P478

P50

P577

P5875

P698

P921

P932

P356

P1433

P1476

P2093

P2860

P304

P31

P356

P433

P478

P50

P577

P5875

P698

P921

P932